Calliditas Therapeutics Stock (NASDAQ:CALT), Quotes and News Summary

Q: What sector and industry does Calliditas Therapeutics (CALT) operate in?

Calliditas Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Calliditas Therapeutics Stock (NASDAQ: CALT) stock price, news, charts, stock research, profile.

Open	$19.440
Close	$19.501
Volume / Avg.	3.791K / 7.272K
Day Range	18.484 - 20.150
52 Wk Range	15.250 - 29.300
Market Cap	$523.319M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	-
Days to Cover	1

Recent News

Palo Alto Networks Issues Weak Outlook, Joins Teladoc Health, SolarEdge Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures were lower this morning, with the Dow futures trading lower by around 70 points on Wednesday.

Avi Kapoor

What's Going On With Vera Therapeutics Stock Today?

Vera Therapeutics' significant market movements! Discover the latest on atacicept in IgA nephropathy trials, analyst ratings, and FDA approvals.

Vandana Singh

Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Calliditas Therapeutics AB

Sector

Health Care

Industry

Pharmaceuticals

Calliditas Therapeutics AB is a commercial-stage biopharma company focused on identifying, developin...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Calliditas Therapeutics (CALT) stock?

You can purchase shares of Calliditas Therapeutics (NASDAQ: CALT) through any online brokerage.

View our list of the best stock brokerages.

Who are Calliditas Therapeutics's (CALT) competitors?

Other companies in Calliditas Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).

What is the target price for Calliditas Therapeutics (CALT) stock?

The latest price target for Calliditas Therapeutics (NASDAQ: CALT) was reported by HC Wainwright & Co. on Thursday, February 22, 2024. The analyst firm set a price target for 50.00 expecting CALT to rise to within 12 months (a possible 171.30% upside). 6 analyst firms have reported ratings in the last year.

Current Stock Price for Calliditas Therapeutics (CALT)?

The stock price for Calliditas Therapeutics (NASDAQ: CALT) is $18.43 last updated April 24, 2024 at 4:50 AM EDT.

Does Calliditas Therapeutics (CALT) pay a dividend?

There are no upcoming dividends for Calliditas Therapeutics.

When is Calliditas Therapeutics (NASDAQ:CALT) reporting earnings?

Calliditas Therapeutics’s Q1 earnings are confirmed for Tuesday, May 14, 2024.

Is Calliditas Therapeutics (CALT) going to split?

There is no upcoming split for Calliditas Therapeutics.

What sector and industry does Calliditas Therapeutics (CALT) operate in?

Calliditas Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-